Categories 
Revolution Medicines Seeks $100 Million IPO
EnterpriseWorks graduate Revolution Medicines filed for an initial public offering of $100 million on January 17, 2020. ... Read More
EnterpriseWorks Graduate SNOOZ Raises $1.35 Million
SNOOZ, an EnterpriseWorks graduate, raised $1.35 million in a seed round led by Serra Ventures. Founded in 2015 by Ma... Read More
PhotoniCare, Inc. Receives Phase I SBIR Award from NIH
PhotoniCare, a startup located in EnterpriseWorks in the University of Illinois Research Park, announced through press r... Read More
Revolution Medicines, EnterpriseWorks Graduate, Secures $100 Million to Target RAS Pathway
Revolution Medicines has secured $100 million in Series C financing that will be used to support the development of the ... Read More
ATSP Innovations Selected for Phase I SBIR by NASA
Jacob Meyer, University of Illinois alumnus and co-founder of ATSP Innovations, announced on June 18 that ATSP Innovatio... Read More
Reconstruct Receives $7.7 Million Series A Investment Led By Cultivation Capital
Reconstruct, a Research Park startup, has closed a $7.7 million series A round led by Cultivation Capital. Investors als... Read More
Research Park Development Partner Atkins Provides Gift for Baseball Training Center
The University of Illinois Division of Intercollegiate Athletics will break ground on a state-of-the-art indoor practice... Read More
DPI Funding to Support Research Park Growth
Part of the state funding allocated to the University of Illinois for the Discovery Partners Institute and its statewide... Read More
Photonicare awarded $2.1 million SBIR funding for patient trials
A Research Park startup is making great strides in providing healthcare providers with better diagnostic tools. The Nati... Read More
Revolution Medicines Makes $50mil Deal
EnterpriseWorks incubator graduate, Revolution Medicines, sold the sharing rights to one of their leading drug candidate... Read More